Entity Common Stock, Shares Outstanding of Tengjun Biotechnology Corp. from 17 Feb 2011 to 10 Aug 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tengjun Biotechnology Corp. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 17 Feb 2011 to 10 Aug 2023.
  • Tengjun Biotechnology Corp. Entity Common Stock, Shares Outstanding for the quarter ending 10 Aug 2023 was 100,711,196, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Tengjun Biotechnology Corp. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 100,711,196 +10,402,027 +12% 10 Aug 2023 10-Q 15 Aug 2023 2023 Q2
Q1 2023 99,309,169 +34,000,000 +52% 31 Mar 2023 10-K 17 Apr 2023 2022 FY
Q3 2022 96,309,169 +50,285,710 +109% 09 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 90,309,169 +44,285,710 +96% 09 Aug 2022 10-Q/A 16 Sep 2022 2022 Q2
Q1 2022 65,309,169 +19,525,710 +43% 31 Mar 2022 10-K 31 Mar 2022 2021 FY
Q3 2021 46,023,459 +240,000 +0.52% 20 Oct 2021 10-Q 20 Oct 2021 2021 Q3
Q2 2021 46,023,459 +240,000 +0.52% 20 Jul 2021 10-Q 20 Jul 2021 2021 Q2
Q1 2021 45,783,459 0 0% 17 Feb 2021 10-K 17 Feb 2021 2020 FY
Q3 2020 45,783,459 +2,646,919 +6.1% 20 Oct 2020 10-Q 20 Oct 2020 2020 Q3
Q2 2020 45,783,459 +7,646,919 +20% 24 Jul 2020 10-Q 24 Jul 2020 2020 Q2
Q1 2020 45,783,459 +7,646,919 +20% 16 Apr 2020 10-Q 16 Apr 2021 2021 Q1
Q3 2019 43,136,540 +5,000,000 +13% 25 Oct 2019 10-Q 25 Oct 2019 2019 Q3
Q2 2019 38,136,540 0 0% 26 Jul 2019 10-Q 26 Jul 2019 2019 Q2
Q1 2019 38,136,540 0 0% 08 Mar 2019 10-K 08 Mar 2019 2018 FY
Q3 2018 38,136,540 0 0% 16 Oct 2018 10-Q 16 Oct 2018 2018 Q3
Q2 2018 38,136,540 +643,420 +1.7% 27 Jul 2018 10-Q 27 Jul 2018 2018 Q2
Q1 2018 38,136,540 +643,420 +1.7% 20 Apr 2018 10-Q 23 Apr 2018 2018 Q1
Q3 2017 38,136,540 +643,420 +1.7% 27 Oct 2017 10-Q 27 Oct 2017 2017 Q3
Q2 2017 37,493,120 +1,050,001 +2.9% 03 Aug 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 37,493,120 +1,050,001 +2.9% 27 Mar 2017 10-K 27 Mar 2017 2016 FY
Q3 2016 37,493,120 +1,050,001 +2.9% 01 Nov 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 36,443,119 0 0% 14 Jul 2016 10-Q 29 Jul 2016 2016 Q2
Q1 2016 36,443,119 0 0% 30 Mar 2016 10-K 30 Mar 2016 2015 FY
Q3 2015 36,443,119 0 0% 09 Nov 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 36,443,119 10 Aug 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 36,443,119 0 0% 06 Apr 2015 10-K 14 Apr 2015 2014 FY
Q3 2014 36,443,119 10 Nov 2014 10-Q 12 Nov 2014 2014 Q3
Q1 2014 36,443,119 31 Mar 2014 10-Q 04 Jun 2014 2014 Q1
Q4 2013 36,443,119 +32,143,119 +748% 31 Dec 2013 10-K 09 Apr 2014 2013 FY
Q2 2013 4,300,000 0 0% 01 Aug 2013 10-Q 13 Aug 2013 2013 Q2
Q4 2012 4,300,000 31 Dec 2012 10-K/A 10 May 2013 2012 FY
Q3 2012 4,300,000 -4,000,000 -48% 30 Sep 2012 10-Q 15 Nov 2012 2012 Q3
Q2 2012 4,300,000 -5,075,000 -54% 31 Jul 2012 10-Q/A 09 Aug 2012 2012 Q2
Q1 2012 4,300,000 0 0% 17 Apr 2012 10-Q 19 Apr 2012 2012 Q1
Q3 2011 8,300,000 18 Oct 2011 10-Q 19 Oct 2011 2011 Q3
Q2 2011 9,375,000 15 Jul 2011 10-Q/A 19 Aug 2011 2011 Q2
Q1 2011 4,300,000 17 Feb 2011 10-K 23 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.